DS-8500a + Rosuvastatin
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Pharmacokinetics in Healthy Volunteers
Conditions
Drug Pharmacokinetics in Healthy Volunteers
Trial Timeline
May 12, 2015 → Jul 6, 2015
NCT ID
NCT03699774About DS-8500a + Rosuvastatin
DS-8500a + Rosuvastatin is a phase 1 stage product being developed by Daiichi Sankyo for Drug Pharmacokinetics in Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT03699774. Target conditions include Drug Pharmacokinetics in Healthy Volunteers.
What happened to similar drugs?
8 of 15 similar drugs in Drug Pharmacokinetics in Healthy Volunteers were approved
Approved (8) Terminated (3) Active (5)
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03699774 | Phase 1 | Completed |
Competing Products
20 competing products in Drug Pharmacokinetics in Healthy Volunteers